Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Eli Lilly And Co Reaffirms FY 2013 Revenue Guidance-Conference Call


Thursday, 3 Oct 2013 08:30am EDT 

Eli Lilly And Co announced that it still anticipates fiscal 2013 revenue of between $22.60 billion and $23.40 billion. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenues of $22.99 billion for fiscal 2013. 

Company Quote

63.931
0.819 +1.30%
9:09am EST